Idraparinux or idrabiotaparinux for long-term venous thromboembolism treatment: a systematic review and meta-analysis of randomized controlled trials.
BACKGROUND: Venous thromboembolism (VTE) is a prevalent disease with potential serious consequences. Idraparinux and idrabiotaparinux are two kinds of long-acting pentasaccharides. Evidence has shown that idraparinux and idrabiotaparinux are effective anticoagulants. However, up to now, there is no...
Main Authors: | Yanzhi Song, Xiaodong Li, Settipalli Pavithra, Dong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3835858?pdf=render |
Similar Items
-
A Modular Synthetic Approach to Isosteric Sulfonic Acid Analogues of the Anticoagulant Pentasaccharide Idraparinux
by: Erika Mező, et al.
Published: (2016-11-01) -
Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
by: Wei Wang, et al.
Published: (2020-02-01) -
Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.
by: Freesia Horsted, et al.
Published: (2012-01-01) -
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis
by: Azza Sarfraz MBBS, et al.
Published: (2021-02-01) -
Antidepressant Use and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis
by: Ying Wang, et al.
Published: (2019-01-01)